Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia

被引：0
|
作者：
Barbara de Graaff
Kwang Chien Yee
Philip Clarke
Andrew Palmer
机构：
[1] University of Tasmania,Menzies Institute for Medical Research
[2] University of Tasmania,School of Medicine
[3] University of Melbourne,School of Population and Global Health
来源：
Applied Health Economics and Health Policy | 2018年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 502
页数：7
相关论文
共 50 条
  • [41] Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
    Tatsuo Kanda
    Mitsuhiko Moriyama
    World Journal of Gastroenterology, 2017, (31) : 5645 - 5649
  • [42] Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients
    Nogueras Lopez, F.
    Lopez Garrido, A.
    Ortega Suazo, E. J.
    Vadillo Galles, F.
    Valverde Lopez, F.
    Espinosa Aguilar, M. D.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (02) : 631 - 633
  • [43] Management of Hepatitis C Infection in children in the era of Direct-acting Antiviral Agents
    Karnsakul, Wikrom
    Schwarz, Kathleen B.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (09) : 1034 - 1039
  • [44] Barriers to Treatment of Hepatitis C Virus in the Direct-Acting Antiviral Era
    Ramers, Christian B.
    Liu, Jie
    Frenette, Catherine
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2019, 11 (02) : 92 - 102
  • [45] Direct-acting antiviral treatment of acute hepatitis C virus infections
    Misra, Suresh
    Dieterich, Douglas T.
    Saberi, Behnam
    Kushner, Tatyana
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (08) : 599 - 610
  • [46] Barriers to Treatment of Hepatitis C Virus in the Direct-Acting Antiviral Era
    Christian B. Ramers
    Jie Liu
    Catherine Frenette
    Current Treatment Options in Infectious Diseases, 2019, 11 : 92 - 102
  • [47] Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era
    Kapadia, Shashi N.
    Johnson, Phyllis
    Marks, Kristen M.
    Schackman, Bruce R.
    Bao, Yuhua
    MEDICAL CARE, 2021, 59 (09) : 795 - 800
  • [48] Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges
    Zeng, Haiyan
    Li, Lei
    Hou, Zhouhua
    Zhang, Yapeng
    Tang, Zhongxiang
    Liu, Shuiping
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (07): : 892 - 902
  • [49] CHARACTERIZING ADHERENCE TO DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C INFECTION
    Voils, Corrine
    King, Heather
    Blalock, Daniel
    Thorpe, Carolyn T.
    Kronish, Ian
    Reeve, Bryce
    Hunt, Christine M.
    Boatright, Colleen
    Bolton, Jamiyla
    Gellad, Ziad F.
    GASTROENTEROLOGY, 2018, 154 (06) : S1228 - S1228
  • [50] Hepatitis C direct-acting antiviral treatment completion Comparison ofgeographic, demographic and clinical characteristics in Australia
    Hailstone, Laura
    MacLachlan, Jennifer
    Doyle, Zelda
    Allard, Nicole
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2023, 52 (06) : 391 - 399
12345